Spiro Robotics, Inc.
- Industry
- Medical Devices
- Founded Year
- 2020
- Headquarters
- 4196 Rincon Cir, Palo Alto, CA 94306, United States
- Employee Count
- 10
Key People
- Dimitri Sokolov - Chief Executive Officer
- Vladimir Nekhendzy - Founder
- Mark Ziegler - Principal R&D Mechanical Engineer
- Jackie Dulken - Director of Engineering and Operations
- Amy Salzhauer - Board Member
- Samuel Scofield - Board Observer
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises experienced professionals with over a decade in their respective fields.
A team with over 10 years of experience in relevant fields brings valuable expertise and industry knowledge, enhancing the company's potential for success.
- Clinical Need
-
Aspect: Very Strong
Summary: The company's AI-guided handheld robotic device addresses a critical need in tracheal intubation procedures.
By focusing on improving tracheal intubation, a procedure with high importance and risk, the company targets a very strong clinical need, increasing its value proposition.
- Competition
-
Aspect: First mover
Summary: Spiro Robotics appears to be among the first to offer AI-guided handheld robotic devices for tracheal intubation.
Introducing a novel solution in a niche market allows the company to establish a strong foothold before competitors emerge, potentially leading to significant market share.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing AI-guided robotic devices presents moderate technical challenges.
While the technology is innovative, the development of AI-guided robotics involves complexities that could impact timelines and costs, posing moderate challenges.
- Patent
-
Aspect: Strong
Summary: The company holds 15 granted patents and 9 pending applications.
Holding multiple patents provides intellectual property protection, deterring competitors and potentially increasing the company's valuation.
- Financing
-
Aspect: Medium
Summary: Spiro Robotics has raised $9 million to date and is seeking a Series A round of $15 to $20 million.
While initial funding has been secured, the company needs further investment to achieve regulatory clearance and commercial rollout, indicating a medium financing status.
- Regulatory
-
Aspect: Running FIH
Summary: The company has completed its first-in-human clinical study and is preparing for FDA submission.
Successfully completing initial clinical studies and preparing for FDA submission demonstrates regulatory progress, reducing time to market.
Opportunity Rollup
- Odds of Success
- 3.95
- Peak Market Share
- 5.45
- Segment CAGR
- 3.4%
- Market Segment
- Anesthesia and Respiratory Devices
- Market Sub Segment
- Tracheal Intubation Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.27 |
| 2 | 0.82 |
| 3 | 1.91 |
| 4 | 3.82 |
| 5 | 5.45 |
Key Takeaway
Spiro Robotics is well-positioned to address a significant clinical need with its innovative AI-guided robotic device, supported by a strong team and patent portfolio, though it faces moderate technical challenges and requires additional funding for commercialization.